The state has taken another massive step toward embracing cannabis’s medical benefits—by allowing children to take medical marijuana at school. The law only applies to cannabis oil and other “non-smokeable” marijuana like CBD oil, and requires that students have a medical marijuana card and written permission from their parents and school principal. Basically, the law…
White says a way forward for kratom may involve treating it like an over-the-counter medication such as pseudoephedrine, which require patients to consult with a pharmacist about interactions and health issues. For now, though, the FDA maintains that clinical trials should form the basis of any policy that regulates kratom. The agency doesn’t seem to…
“The status quo for our growing legal cannabis industry is unsustainable,” said State Senator Bob Hertzberg (D—Van Nuys), the bill’s sponsor. “It’s not only impractical from an accounting perspective, but it also presents a tremendous public safety problem. This bill takes a limited approach to provide all parties with a safe and reliable way to…
How did a small nonprofit, with $200 in its bank account just a few years prior, grow to be so influential, so quickly? It may have had the DEA to thank for its growth. AKA’s campaign quickly gained traction when the DEA proposed to schedule the drug. Ash hired lobbyists, scientists, and a legal team. AKA’s success in confronting the…
May 16, the Louisiana House unanimously approved a resolution from state Rep. Frank Hoffmann directing the department to study the plant and products containing kratom. locally, it’s only a minor issue on health officials’ radar — while they may be skeptical of the science of its medicinal use, its impact isn’t as dire as federal warnings suggest. Previous…
As executive director of the People’s Harm Reduction Alliance in Seattle, Shilo Jama said he’s seen people successfully treat their opioid addictions using kratom … Kenneth Thummel PhD. would like it to be carefully studied, which he admits would be more difficult if it is designated a Schedule I drug [through the combined efforts of…
The Botanicial Education Alliance had leading toxicologist William R. Sawyer, Ph.D., D-ABFM conduct a full toxicological review of 30 associated deaths when the DEA was attempting to schedule the plant. Dr. Sawyer found no deaths solely attributed to kratom in the TOXNET data network, and determined there was insufficient toxicological evidence to support Schedule I…
“Since kratom can be grown in your backyard, pharmaceutical companies can’t monopolize it — unless the government outlaws it.” HERE “They (the FDA) kind of cast aside some of the scientific literature that actually models or observed it in actual receptors,” he says. According to Grundmann, that research shows that although kratom binds to opioid…
“There’s a very big obsession, I would say, in the field of getting rid of the addictive properties, but I think what we should focus on is just not killing people to start with [HERE]. If you get rid of respiratory depression [caused by traditional and synthetic opiates], you’re saving 18,000 lives a year from…
The first reports of pharmacological studies on mitragynine appeared in the literature in 1972 (Macko et al., 1972). Researchers at Smith, Kline, and French (SKF) were interested in finding a novel analgesic that would have less liability than the currently utilized opioids (i,e. morphine). Their studies were the most comprehensive at the time and still…
Recent Comments